Scott Burnside
About Scott Burnside
Scott Burnside is the Associate Director and Principal Engineer of Clinical Manufacturing at Bristol Myers Squibb, with extensive experience in process engineering and drug product development.
Company
Scott Burnside is currently working at Bristol Myers Squibb as Associate Director, Principal Engineer, Clinical Manufacturing. Additionally, he is associated with Celgene in a capacity of Principal Engineer for External Manufacturing, Drug Product Development in North Carolina.
Title
Scott Burnside holds the title of Associate Director, Principal Engineer, Clinical Manufacturing at Bristol Myers Squibb. He holds additional responsibilities as Principal Engineer for External Manufacturing, Drug Product Development at Celgene.
Education and Expertise
Scott Burnside earned his B.S. in Chemical Engineering from North Carolina State University, completing his studies between 1999 and 2002. With over fifteen years of experience, he possesses extensive knowledge in quality systems, Quality by Design, validation principles, engineering design, and process control fundamentals. His expertise includes implementing creative solutions to overcome process development and supply challenges.
Professional Background
Scott Burnside's professional career includes significant roles at Celgene, AAIPharma Services, and GlaxoSmithKline. At Celgene, he served as Sr. Technical Lead, Global Clinical Operations from 2014 to 2017, and currently works as Principal Engineer for External Manufacturing, Drug Product Development. At AAIPharma Services, he held various roles including Process Engineer I, II, and III from 2006 to 2014, and Process Engineer II from 2008 to 2012. He began his career at GlaxoSmithKline as Associate Scientist / Process Engineer I from 2003 to 2006.
Achievements
Scott Burnside has a notable record in leading technology transfer and scale-up initiatives. He has orchestrated the development and execution of experimental programs to enhance process robustness, productivity, and cost-efficiency. His experience extends to working in highly matrix-ed, cross-functional organizations where he has successfully implemented novel solutions for process development and supply obstacles.